RO Toolbox vs ChemoPalRx

The RadOnc Toolbox is a resource for health care professionals that is designed to support evidence-based practice. This point-of-care tool compiles frequently accessed references related to the delivery of radiation therapy, including dose constraints, calculators, clinical practice guidelines, staging, and other oncology resources.    The RadOnc Toolbox was created by Malolan Rajagopalan, MD, MBA, who was Principal Investigator of a grant from the ASTRO Foundation, then known as the Radiation Oncology Institute (ROI), that aimed to develop a resource to manage acute and late radiation toxicity. The Foundation assumed responsibility for the RadOnc Toolbox and released the first version in 2016. Since then, the Foundation has continued to add resources and enhance the content.   The redesigned RadOnc Toolbox released by the Foundation in 2023 is produced in collaboration with Red Canvas, LLC.

Safe chemotherapy prescribing remains one of the top priorities for medical institutions and practitioners. While computerized order entry system embedded in electronic health record (EHR) has been shown to enhance the safety and efficiency of chemotherapy prescribing, implementation of such system continue to be challenging for institutions that lack the financial incentives, technological capabilities, and administration buy-in to invest and implement such system. As the result, many medical institutions continue to have practitioners to hand write chemotherapy prescription for cancer patients. In an effort to bridge the gap for safe chemotherapy prescribing for institutions that lack a computerized order entry system in their EMR, ChemoPalRx was developed. ChemoPalRx is a mobile chemotherapy prescribing and reference platform for practitioners. It has over 120 build-in chemotherapy reference template and a 450+ chemotherapy medications library that allows practitioners to safely and efficiently transcribed their chemotherapy prescription into a standardized .pdf format for prescribing. Implementation of this free mobile application would allow for consistency in chemotherapy prescribing with the potential to impact patient outcomes globally.